Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indication of monobenzone pharmaceutical composition for treating cancer

Indication of monobenzone pharmaceutical composition for treating cancer

US Patent 10098852 · Granted Oct 16, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutic2018
Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutic2018
Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutic2018
Pharmaceutical compositions for inhibiting antibiotic-resistant microorganisms a2018
Uses of duloxetine HCL medicament in preparing pharmaceutical treatment of cance2018
Uses of duloxetine HCL medicament in preparing pharmaceutical treatment of cance2018
Uses of duloxetine HCL medicament in preparing pharmaceutical treatment of cance2018
Uses of duloxetine HCL medicament in preparing pharmaceutical treatment of cance2018
Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses th2016
2-phenyl-4-quinolones as anticancer agents2015
2-selenophene-4-quinolones as anticancer agents2015
Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents2015